Blog

Medical Devices

view all

Auto Accidents

view all

Labor Law

view all

FDA and Prescription Drugs

view all

Products Liability

view all

Medical Malpractice

view all

Wrongful Death

view all

Personal Injury

view all

Trasylol

view all

General

view all

News

view all

Library

FDA and Prescription Drugs

Recruiting

Newsletter

General


Napoli Bern Ripka, LLP Blog

Blog Category:

Trasylol

    6/11/2008
    Paul Napoli
    Comments (1)

    Trouble for Bayer as Lawsuits Draw Near

    The suspension of Trasylol, a drug used in heart surgeries sales that has been proven to be fatal, has caused for much talk. Trasylol lawsuits from the families of those affected by the drug’s side-effects will be filed soon, and a Trasylol class-action lawsuit can not be far off. With fatalities over 22,000, Bayer is going to be struggling to find a way out. The drug was speculated to have problems back in 2006, yet it was still approved by the FDA. The reason for this is that Bayer failed to present their research about the relation of kidney failure & Trasylol to the FDA in their September 2006 meeting. The chairman of that FDA advisory panel, Dr. William Hiatt, said that he would have voted for a Trasylol recall back in 2006 if Bayer had not withheld the data from their study


                The high cost of Trasylol has also posed questions due to the fact that it was a lot more expensive at $1,250, than of competitors at $150. This makes us wonder if Bayer was not only producing a defection medication, but also gouging prices from those who were administered Trasylol. What we do know is that Bayer is going to need more than a drug to cure there worries


    Napoli Bern Ripka LLP is an experienced firm in the medical negligence field and can provide you with the right information on how to proceed with your case. If you or a loved one have suffered as a result of Trasylol side effects such as kidney failure, heart attack, or stroke you may be entitled to compensation. We are here to help you questions that you may have regarding Trasylol side effects, a possible Trasylol class action lawsuit, or any other type of Trasylol litigation.

    Read More about "Trouble for Bayer as Lawsuits Draw Near"


    6/11/2008
    Paul Napoli
    Comments (0)

    Bayer Recalls Popular Drug Used In Heart Surgery

    Bayer Pharmaceutical, the large drug manufacturer, has announced that it has taken its remaining stock of Trasylol out of hospitals. This anti-bleeding medication has been linked to causing kidney damage and death in over 22,000 cases. The reason that Bayer recalled the drug was in response from studies that show Trasylol nearly doubled the death rate in comparison to cheaper alternative medications that were already established in the market. These studies that proved Trasylol, also called aprotinin, is more dangerous when used in heart surgeries were given to Bayer nearly two years before it was taken off the market. Bayer even did their own study, in which the finding also discovered the fatal side effects of the drug.


    Now that Trasylol has been taken off the market it is time to recoup all that has been lost. This is another example of large drug company whose questionable motives have cost numerous lives and much grief. The firm of Napoli Bern Ripka, LLP represents victims of such second-rate care and negligence. We have the experienced legal team that has successfully represented thousands of clients injured by medical drugs such as Fen-phen, Baycol, and Rezulin, and are here to help you with any Trasylol questions you may have.

    Read More about "Bayer Recalls Popular Drug Used In Heart Surgery"